迈阿密肝脏质子治疗会议共识报告
Consensus Report From the Miami Liver Proton Therapy Conference.
作者信息
Chuong Michael D, Kaiser Adeel, Khan Fazal, Parikh Parag, Ben-Josef Edgar, Crane Christopher, Brunner Thomas, Okumura Toshiyuki, Schreuder Niek, Bentzen Søren M, Gutierrez Alonso, Mendez Romero Alejandra, Yoon Sang Min, Sharma Navesh, Kim Tae Hyun, Kishi Kazushi, Moeslein Fred, Hoffe Sarah, Schefter Tracey, Hanish Steven, Scorsetti Marta, Apisarnthanarax Smith
机构信息
Baptist Hospital of Miami, Miami Cancer Institute, Miami, FL, United States.
University of Maryland Medical Center, Baltimore, MD, United States.
出版信息
Front Oncol. 2019 May 31;9:457. doi: 10.3389/fonc.2019.00457. eCollection 2019.
An international group of 22 liver cancer experts from 18 institutions met in Miami, Florida to discuss the optimal utilization of proton beam therapy (PBT) for primary and metastatic liver cancer. There was consensus that PBT may be preferred for liver cancer patients expected to have a suboptimal therapeutic ratio from XRT, but that PBT should not be preferred for all patients. Various clinical scenarios demonstrating appropriateness of PBT vs. XRT were reviewed.
一个由来自18个机构的22名肝癌专家组成的国际小组在佛罗里达州迈阿密开会，讨论质子束疗法（PBT）在原发性和转移性肝癌中的最佳应用。与会专家达成共识，对于预计从X射线放疗（XRT）中获得次优治疗比率的肝癌患者，PBT可能是首选，但并非所有患者都应首选PBT。会议回顾了各种表明PBT与XRT适用性的临床情况。
Zotero 插件